We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MB:NASDAQMasterBeef Group Analysis

Data as of 2026-05-19 - not real-time

$6.50

Latest Price

8/10Risk

Risk Level: High

Executive Summary

MasterBeef Group trades at $6.50, sitting just below its 20‑day SMA of 7.14 and well under the 200‑day SMA of 7.49, indicating a price lag to its longer‑term trend. The RSI of 46 suggests neutral momentum, while the MACD histogram is negative and the signal line is labeled bearish, reinforcing short‑term downside pressure. Volatility is extreme at 114% over the past 30 days, yet beta is only 0.10, implying the stock’s swings are largely idiosyncratic rather than market‑driven. The Fear & Greed Index reads “Extreme Greed,” a market mood that may be inflating price expectations despite weak fundamentals.
Fundamentally, the company reports a -11.4% profit margin, negative operating cash flow of $12.6 M, and a debt‑to‑equity ratio exceeding 445, signaling severe financial strain. The price‑to‑book ratio of 12.8 is far above the industry norm, while the price‑to‑sales of 0.24 hints at a low valuation relative to revenue but is offset by a massive 76% max drawdown and a negative ROE of -1.38%. The only bright spot is a announced launch of a premium Thai tea and dessert franchise, which could provide a modest revenue boost if execution succeeds.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Price below 20‑day SMA and bearish MACD
  • Extreme short‑term volatility
  • Weak cash flow and negative margins

Medium Term

1–3 years
Cautious
Model confidence: 6/10

Key Factors

  • High debt load and poor profitability
  • Uncertain impact of new franchise launch
  • Continued liquidity constraints

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Potential upside from franchise expansion if successful
  • Structural challenges in the restaurant sector
  • Risk of further capital deterioration

Key Metrics & Analysis

Financial Health

Revenue Growth-11.70%
Profit Margin-11.36%
ROE-138.29%
ROA-6.10%
Debt/Equity445.27
P/B Ratio12.8
Op. Cash Flow$-12626408
Free Cash Flow$-4650798

Technical Analysis

TrendNeutral
RSI46.5
Support$5.50
Resistance$9.50
MA 20$7.14
MA 50$6.36
MA 200$7.49
MACDBearish
VolumeStable
Fear & Greed Index89.25

Valuation

GradeOvervalued
TypeValue

Risk Assessment

Beta0.10
Volatility114.46%
Sector RiskHigh
Reg. RiskMedium
Geo RiskHigh
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.